Agomab Therapeutics NV 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
AgomAb Therapeutics NV has filed an addendum to a non-residential lease agreement with Galchimia, S.A., modifying terms related to user access and rent.